Thursday, 13 Dec 2018

You are here

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings.  Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

  1. Metanalysis of checkpoint inhibitor (nivolumab, pembrolizumab or atezolizumab) shows high rates of hypothyroidism (OR 7.6), pneumonitis (5.4), colitis (2.9), hypophysitis (3.4), rash (2.4), fatigue (32%), diarrhea (19%) and  a >20% frequency of arthraligia or back pain. https://t.co/1WMuRRCWZN
  2. Science Translocation of a gut microbe, Enterococcus gallinarum to tissues triggers autoimmunity in mice with a genetic predispositon to lupus. Vancomycin prevented mortality by suppressing E. gallinarum and eliminating pathogenic autoantibodies and T cells. https://t.co/02vZstzQ86
  3. An Italian 89 pt GPA study finds ENT involvement in 72%; they tend to be younger with less renal disease. Sinonasal symptoms were seen in 58% and otitis media/otomastoiditis in 35%. ENT involvement predicted better outcomes and milder GPA with risk of lower renal disease and mortality rate. https://t.co/UWjzzloxm9
  4. Comparing patients who travel by air vs. those by land to/from hospital after TKR, THR, finds 3 fold higher rates of venous thromboembolic events (VTE) (1.64% vs 0.58%) https://t.co/n5cu9eeqz6
  5. Opportunistic Infections in RA Rare with Biologics   
  6. Bone Marrow Edema Found in SI Joint of Athletes  
  7. Plaquenil During Lupus Pregnancy Lessens Flares 
  8. CARES Study- More CV Deaths with Febuxostat 

“A goal without a plan is just a wish.” ― Antoine de Saint-Exupéry (goals specific, measureable, attainable, realistic & timely - Christine Bundy)

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Rheumatologists' Comments

Many gout patients placed on febuxostat due to renal diseases. Could presence kidney problems raise risk adverse cardiovascular events for those on febuxostat?

More Like This

RheumNow Podcast – Can RA Be Prevented (12.7.18)

Dr. Jack Cush reviews the news and new journal articles from the past week on RheumNow.com:

Chronic Kidney Disease Increasing in the U.S.A.

JAMA has published the Global Burden of Disease (GBD) study showing that that, from 2002 to 2016, the US burden of chronic kidney disease (CKD) increased, with some states exhibiting more than twice the burden as others. The increase in burden was associated with increased metabolic and dietary risk exposure that manifested in increased probability of death due to diabetic CKD, especially for those between 20 to 55 years.  

RheumNow Podcast – To Needle or Not to Needle (11.30.18)

Dr. Jack Cush updates the news and reports from the past week at RheumNow.com:

Physical Activity Guidelines for Americans

The data are clear and disappointing: despite the well-known health benefits, four out of five US adults are not active physically.  JAMA has published the new US Physical Activity Guidelines for Americans, so that health professionals and policy makers can promote lifestyle changes and awareness of the the health benefits of physical activity.

The RheumNow Podcast – Heartbreak of Methotrexate (11.16.18)

Dr. Jack Cush reviews the news from the past week at RheumNow.com.